SmithRx is expanding the Connect 360 Autoimmune Program to include the Stelara biosimilars.
March 4 at 9 a.m. PT/ 12 p.m. ET | Connect Insiders Webinar
Alissa Johnson, Director of Clinical Strategy, will delve into the details of biosimilars, the exciting Connect 360 Autoimmune program updates, and answer your questions.
Learn about biosimilars launching in 2025, including expanded clinical options for members with enhanced savings for employers.
Get an early peek into the Connect 360 Autoimmune program updates, including Stelara biosimilars.
Alissa Johnson, PharmD, BCPS
Senior Director, Clinical Strategy, SmithRx
